The Global Congress on Obesity, Diabetes and Metabolic Health addresses obesity, diabetes, and metabolic health through innovations in pharmacology, digital health, personalized care, and global management strategies.
Highlights
- Oral GLP-1 Receptor Agonists
- CRISPR-Edited Islet Cells for Type 1 Diabetes
- Once-Weekly Insulin Therapies
- Dual Incretin Agonists (GLP-1 + GIP)
- Implantable Continuous Glucose Monitors (CGMs)
- GLP-1 Receptor Agonists for Cardiovascular & Renal Protection
- Digital Twin Models for Personalized Diabetes Care
- Automated Insulin Delivery Systems / Closed-Loop Pumps
- AI & Machine Learning for Glucose Prediction and Diabetes Management
- Continuous Ketone Monitoring for High-Risk Patients
- Personalized Pharmacological Strategies
- ADA Standards of Care in Diabetes
- Real-World Evidence & Outcomes in Diabetes Treatment
- Evidence-Based Dietary Interventions
- Global Targets & Strategies to Halt Diabetes Rise
- Management of Comorbidities in Diabetes (Obesity, Hypertension, Dyslipidemia)
- Diabetes Education & Awareness Programs
- Access to Affordable Insulin Worldwide
- Collaborative International Research in Diabetes
- Innovations in Diabetes Care in Low-Resource Settings
Who should Attend
- Obesity Specialists and Nutritionists
- Endocrinologists and Diabetologists
- Primary Care Physicians and Healthcare Providers
- Researchers and Academicians
- Pharmaceutical and Medical Device Industry Professionals
- Policy Makers and Public Health Experts
- Students and Trainees
